Clinical Trial Update: Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Insulin Fiasp to Insulin NovoRapid during pregnancy in women with pre-existing diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus During Pregnancy
• Pregnancy Complications

Drugs mentioned

• Insulin Fiasp (insulin aspart)
• Insulin NovoRapid (insulin lispro)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Diabetes Mellitus, Pregnancy Complications | Phase 3 | Status: COMPLETED